Blog Archives

2017 Symposium Welcome

Larry Gold, Ph.D. is the Founder and Chairman of the board, and past CEO of SomaLogic. Prior to SomaLogic, he founded NeXagen, Inc., which later became NeXstar Pharmaceuticals, Inc. In 1999, NeXstar merged with Gilead Sciences, Inc. to form a global organization committed to the discovery, development and commercialization of novel products that treat infectious diseases. Before forming NeXagen, he also co-founded and served as Co-Director of research at Synergen, Inc., a biotechnology company later acquired by Amgen, Inc.

Dispatches from the Frontiers of Modern Medicine

Primary Care for the Twenty-First Century

Targeted Nucleases—Human Gene Therapy 2.0?

“Damn the Compass, Full Speed Ahead”: Why Quality Beats Quantity in Drug R&D